SAN DIEGO--(BUSINESS WIRE)--The suit alleges defendants issued false statements re: AstraZeneca business and prospects, resulting in its stock trading at inflated prices.
Related news
AZN INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that AstraZeneca PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
www.businesswire.com 04-01-2025 02:55 0.5 Minutes reading
